Linkedin

News and events

  • All
  • Events
  • Press releases
  • Publications
All
  • All
  • Events
  • Press releases
  • Publications

ExeVir Announces Michael Garrett as New Chief Executive Officer

Company developing antibody therapeutics against emerging viral threatsMichel
November 18, 2024
Read More

Poster ID Week 2024

Poster presented by Florence Herschke at ID Week 2024, October 16-19, 2024, Los Angeles, USA
November 8, 2024
Read More

Empowering the Immunocompromised and Elderly: ExeVir Bio presents promising XVR013m data at ID Week 2024

October 17, 2024
Read More

ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody Against the SARS-CoV-2 Variant JN.1

Photo by Önder Örtel on Unsplash
June 4, 2024
Read More

Join us at the Asia Dengue Summit 2024!

Connect with Florence Herschke, PhD, our head of preclinical development, and Tessa Van Royen, one of our research scientists, next week at the 7th Asia ...
May 30, 2024
Read More